Literature DB >> 10970801

Role of pro-297 in the catalytic mechanism of sheep liver serine hydroxymethyltransferase.

R Talwar1, V Leelavathy, J V Krishna Rao, N Appaji Rao, H S Savithri.   

Abstract

Serine hydroxymethyltransferase belongs to the alpha class of pyridoxal-5'-phosphate enzymes along with aspartate aminotransferase. Recent reports on the three-dimensional structure of human liver cytosolic serine hydroxymethyltransferase had suggested a high degree of similarity between the active-site geometries of the two enzymes. A comparison of the sequences of serine hydroxymethyltransferases revealed the presence of several highly conserved residues, including Pro-297. This residue is equivalent to residue Arg-292 of aspartate aminotransferase, which binds the gamma-carboxy group of aspartate. In an attempt to change the reaction specificity of the hydroxymethyltransferase to that of an aminotransferase and to assign a possible reason for the conserved nature of Pro-297, it was mutated to Arg. The mutation decreased the hydroxymethyltransferase activity significantly (by 85-90%) and abolished the ability to catalyse alternative reactions, without alteration in the oligomeric structure, pyridoxal 5'-phosphate content or substrate binding. However, the concentration of the quinonoid intermediate and the extent of proton exchange was decreased considerably (by approx. 85%) corresponding to the decrease in catalytic activity. Interestingly, mutant Pro-297 Arg was unable to perform the transamination reaction with L-aspartate. All these results suggest that although Pro-297 is indirectly involved in catalysis, it might not have any role in imparting substrate specificity, unlike the similarly positioned Arg-292 in aspartate aminotransferase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970801      PMCID: PMC1221319     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  A novel intermediate in the interaction of thiosemicarbazide with sheep liver serine hydroxymethyltransferase.

Authors:  J K Acharya; N A Rao
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

2.  X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase.

Authors:  C A McPhalen; M G Vincent; J N Jansonius
Journal:  J Mol Biol       Date:  1992-05-20       Impact factor: 5.469

3.  An efficient vector-primer cDNA cloning system.

Authors:  D C Alexander
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 4.  Serine hydroxymethyltransferase.

Authors:  L Schirch
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1982

5.  His230 of serine hydroxymethyltransferase facilitates the proton abstraction step in catalysis.

Authors:  R Talwar; J R Jagath; N A Rao; H S Savithri
Journal:  Eur J Biochem       Date:  2000-03

Review 6.  Molecular organization, catalytic mechanism and function of serine hydroxymethyltransferase--a potential target for cancer chemotherapy.

Authors:  N A Rao; R Talwar; H S Savithri
Journal:  Int J Biochem Cell Biol       Date:  2000-04       Impact factor: 5.085

7.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

8.  Function of the active-site lysine in Escherichia coli serine hydroxymethyltransferase.

Authors:  D Schirch; S Delle Fratte; S Iurescia; S Angelaccio; R Contestabile; F Bossa; V Schirch
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Interactions of methoxyamine with pyridoxal-5'-phosphate-Schiff's base at the active site of sheep liver serine hydroxymethyltransferase.

Authors:  J K Acharya; V Prakash; A G Rao; H S Savithri; N A Rao
Journal:  Indian J Biochem Biophys       Date:  1991 Oct-Dec       Impact factor: 1.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.